Turning traction into scalable, enterprise-level growth.

In health innovation, momentum isn’t the challenge; precision is. At a certain stage, healthtech and medtech leaders find that what once worked no longer scales. Revenue plateaus, GTM efforts diverge, and the market narrative becomes less clear.

It’s not a lack of effort; it’s a lack of strategic cohesion. 

That’s exactly what our Strategic Growth Consulting restores. We partner with growth-stage and PE-backed leaders to realign strategy, narrative, and execution, so every commercial lever drives measurable enterprise value.

Our team can help you identify the gaps between traction, valuation, and scalability and define your next phase of expansion.

Book a strategic growth review

The growth challenge in health innovation

Once you establish product market fit, the next barrier isn’t validation; it’s alignment.

You’ve proven the model. You have clinical validation, regulatory clearance, and paying customers. Yet the growth curve stalls, and the valuation story doesn’t fully reflect the potential.

Across the health innovation landscape, we see the same friction points:

  • Valuation discount despite commercial traction

  • Inconsistent narrative across stakeholders

  • Misaligned GTM execution

  • Board pressure for scalability

Strategic growth isn’t about louder marketing or bigger sales budgets. It’s about defining, operationalizing, and aligning your growth narrative across every touchpoint that drives valuation.

That’s the foundation of how we help health innovators scale.


Where strategic alignment becomes commercial acceleration

We anchor our framework in three core growth programs from our strategic foundation:

Strategic foundation

We start by diagnosing where clarity breaks down across market perception, buyer journey, and internal alignment. Through structured research and stakeholder analysis, we identify the growth levers most directly tied to enterprise value.

This include:

  • Market opportunity architecture and positioning clarity

  • Competitive intelligence and differentiation mapping

  • Alignment around your unique value logic, the “why you win” statement that drives revenue and valuation

Positioning & valuation strategy

Once your foundation is defined, we refine how that value translates to the market and the boardroom.

Our valuation-driven positioning process ensures your commercial story aligns with investor logic and buyer impact.

We help you:

  • Quantify differentiation in terms that resonate with investors and acquirers

  • Align go-to-market priorities to enterprise value creation

  • Create consistency across internal and external narratives

Commercial acceleration & GTM alignment

Finally, we operationalize your strategy. That means translating insights into motion and embedding the strategy into your GTM engine so teams can execute with precision and speed.

We guide you through:

  • GTM readiness assessment and playbook development

  • Cross-functional alignment between marketing, sales, and product

  • Growth enablement frameworks that turn clarity into performance

When you bring these three elements together, foundation, positioning, and acceleration, you don’t just grow revenue. You grow valuation, investor confidence, and market momentum simultaneously.

Turn clarity into commercial momentum

Our framework for accelerated enterprise value

At Legacy DNA, growth consulting isn’t about adding layers of complexity; it’s about stripping away what’s slowing you down.

Our Strategic Growth Framework helps leadership teams identify, prioritize, and activate the levers that directly impact scale.

Market intelligence & opportunity architecture

We analyze the intersection between your market position, buyer evolution, and growth potential. This includes sizing expansion opportunities, mapping adjacent markets, and uncovering unmet value pools

The outcome: a clear, data-backed growth thesis that aligns commercial execution with investor expectations.

Narrative alignment across commercial channels

We ensure your story moves seamlessly from the boardroom to the buyer. Your investor narrative, product positioning, and go-to-market messaging should reinforce each other rather than compete for attention.

We operationalize messaging consistency so that your leadership, sales, and marketing teams speak with one voice, one that moves markets, not just minds.

GTM readiness & operational activation

Growth requires precision execution.

We work with your commercial leaders to translate strategy into repeatable systems, refining target segmentation, channel prioritization, and customer journey activation.

That means faster sales cycles, more efficient marketing spend, and measurable ROI.

Portfolio-Level scalability

For multi-asset or PE-backed organizations, growth requires cohesion at scale.

We develop frameworks that create alignment across the portfolio, ensuring each brand or business unit aligns with a unified enterprise value story.

This portfolio-level clarity reduces friction, accelerates decision-making, and unlocks higher valuation multiples across your holdings.


Growth in action: real results from strategic realignment

Legacy DNA partnered with BioPlus Specialty Pharmacy to refine brand consistency, refresh market positioning, and strengthen go-to-market execution. The results: a 2x increase in revenue and a 202% increase in gross profit, with the company recognized as one of the nation’s top specialty pharmacies.

“Roxy and her team brought a freshness and consistency to our brand that transformed our performance. It’s had a tremendous impact.” — Dr. Steve Vo, Founder & CEO, BioPlus Specialty Pharmacy.

Explore more success stories

Strategic growth isn’t a workshop, it’s a discipline

Health innovation moves fast, and so do we. Our team helps you turn strategic clarity into measurable outcomes that scale.

  • Your strategy performs in the market, not on paper: We close the gap between insight and execution. Our team builds systems your people can run, driving adoption, revenue, and valuation growth.

  • Every move drives enterprise value: From positioning to GTM execution, each initiative strengthens valuation multiples and accelerates ROI.

  • You see results quickly: Our sprint model gives leadership teams precision, speed, and traction without delay.

  • You work with people who understand your world: Our strategists bring experience from healthtech, medtech, and investor ecosystems. We create strategies that work in practice, not just theory.


Ready to move beyond traction?

If your organization has hit the “complexity ceiling” with strong traction but slowed momentum, it’s time for a deeper look.

We’ll help you:

  • Identify your primary growth constraints.

  • Map alignment gaps between strategy, execution, and valuation.

  • Define next-step priorities for scalable enterprise growth.

Request a growth acceleration diagnostic

Frequently Asked Questions

  • We partner with mid-market healthtech and medtech CEOs, commercial leaders, and PE-backed operators who already have traction but need to scale strategically, aligning growth, GTM, and valuation narratives across their enterprise or portfolio.

  • Within 90 days, clients receive a Growth Readiness Assessment, an aligned market and investor narrative, and a GTM activation roadmap linking commercial performance to enterprise value. Every deliverable is built to drive board-level clarity and measurable growth momentum.

  • Strategic Growth Consulting expands and operationalizes growth levers across your organization. The Positioning & Valuation Strategy defines how those levers translate into premium multiples.

  • Strategic growth is the intersection of traction, alignment, and enterprise readiness, turning performance into value. It’s growth that’s:

    • Aligned with market opportunity and investor logic

    • Scalable across business units

    • Sustainable through operational execution

  • We help leaders overcome:

    • Valuation discounts despite strong performance

    • Stalled growth curves post-traction

    • Misalignment between commercial execution and enterprise value

    • Fragmented GTM narratives across investor and customer audiences

  • We use AI to accelerate diagnostics, segmentation, and opportunity modeling, always under human strategic oversight. Every output is expert-validated and commercially grounded, ensuring insight speed never compromises rigor.

  • We partner with PE and growth equity firms to accelerate value creation by aligning GTM and valuation narratives across assets, conducting growth diagnostics, and embedding commercialization frameworks that drive exit multiples.

  • Yes. We act as the strategic growth layer, providing frameworks, leadership, and clarity so internal teams execute more effectively and with higher ROI.

  • If you’re a mid-market CEO or PE partner preparing for a premium exit, under pressure to scale, or struggling to align brand, demand, and valuation, we can help.

  • Most leaders begin with a Sprint, a focused 90-day engagement that delivers enterprise-ready assets and valuation clarity. From there, we scale into a long-term growth partnership.

This small, independent specialty pharmacy wanted to dance with the giants, but first, they needed to find their rhythm. Armed with stronger branding, positioning, and thought leadership, they learned new routines. It wasn’t long before they could jump on the dance floor and hustle their way to explosive growth (968% in one decade), taking their pharmacy from millions to billions.

Embracing a paradigm shift from traditional marketing, this tech platform undertook a comprehensive overhaul. Using more strategic go-to-market processes, they ushered their specialty pharmacy innovations into the modern era. Today, they continue to lead the way with their pioneering reputation and forge a path towards a more transformative future.

Armed with firsthand insights and feedback from numerous patients, this physician had a uniquely clear vision of the market's requirements. The problem was that he was up against a saturated landscape commanded by well-established household brands with deep pockets and enduring customer loyalty. The challenge lay in carving a distinctive niche. Leveraging a dynamic and robust commercialization strategy along with a bold brand identity, his product managed to not only capture the spotlight but also secure coveted shelf space within prominent big-box retailers.

It’s easy to coast along when you’re making a profit in an industry that’s full of growth and opportunity. But this independent pharmacy buying group wanted to take it to the next level. With a robust strategic marketing plan and by leveraging modern tools, tactics, and best practices, they were able to drive rapid growth and transform into an online destination for independent pharmacy owners.

With a lean team and limited resources, this company harnessed a late-entrant advantage, crafting an ingenious brand strategy that utilized a SaaS model and AI to creatively exploit the gaps left by dominant market players. The result? They were not only able to compete against industry giants, they went on to absorb their top competitor in just two years, reshaping the market landscape.

In an industry barreling toward commoditization, this specialty pharmacy recognized the urgency of setting itself apart. Through a blend of enhanced, strategic branding and impactful messaging, they were able to secure their market position in the hearts and minds of patients and stakeholders, making them a desirable target for acquisition.

This specialty pharmacy built a strong name for itself in the HCV field - but struggled to stay visible in a saturated market. Leadership knew marketing resources were stretched thin, and they had no real strategic plan in place, but the market was experiencing massive growth. Capitalizing on that growth meant they needed a plan - a marketing plan. Two years later, with a strategic marketing plan and enhanced foundational assets in place, their net worth soared from $50 million to $500 million, making them an irresistible acquisition for the fifth-largest pharmacy in the United States.

This digital health startup set out to develop an early adoption strategy and a clear path to market. While developing the strategies that would help them avoid pitfalls, circumvent failure, and recognize opportunities, COVID hit. Armed with their newly acquired early adoption vision, they were able to confidently perform a powerful pandemic pivot to success.

As seen on